First-in-Human Implantation of a New Transcatheter Tricuspid Valve Replacement System

Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the Mo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JACC. Case reports 2023-05, Vol.14, p.101841, Article 101841
Hauptverfasser:	Sondergaard, Lars, Møller, Jacob Eifer, De Backer, Ole, Møller-Sørensen, Peter Hasse, Cheng, Yanping, Rossing, Kasper, Smerup, Morten, Quadri, Arshad
Format:	Artikel
Sprache:	eng
Schlagworte:	Case Report percutaneous transcatheter valve therapy tricuspid regurgitation valve replacement
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Therapeutic options for patients with isolated severe to torrential tricuspid regurgitation have been limited. Because a surgical option is often not attractive, new catheter-based therapies are emerging. We report the first-in-human percutaneous transcatheter tricuspid valve replacement with the MonarQ system in a 75-year-old female patient with severely symptomatic torrential tricuspid regurgitation. (Level of Difficulty: Advanced.) [Display omitted]
ISSN:	2666-0849 2666-0849
DOI:	10.1016/j.jaccas.2023.101841